Phase 3 trial of SMS 201-995 pa LAR (SMS pa LAR) and continuous infusion (CI) 5-FU in unresectable stage II, III, and IV pancreatic cancer

1 Citations

Journal

Citations (1)*help

See more

Details 詳細情報について

  • CRID
    1570572701245680000
  • NII Article ID
    10027292905
  • Data Source
    • CiNii Articles

Report a problem

Back to top